CIK: 1261506 - Address: C/o Repligen Corporation, 41 Seyon St., Bldg 1, Ste 100, Waltham, MA 02453
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret218-0-141196515
P%wins50385038638854

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/6/21 16:29
5/4/21
VACCVaccitech PlcDEHealthDrugPharmaceutical PreparationsDawes Karen AX0DP2917.0002New2D
6/21/13 14:16
6/21/13
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADP87.7021334D113781718-19-8-6-154283569190
3/6/13 20:07
3/6/13
DEPODepomed IncCAHealthDrugPharmaceutical PreparationsDawes Karen ACADP125.9642338D-30-413-1-4-11-10-821-7124137
8/15/11 09:02
8/12/11
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADP353.490107151D-375-28-10-4-7142-4-3-32137
6/15/11 18:30
6/14/11
DEPODepomed IncCAHealthDrugPharmaceutical PreparationsDawes Karen ACADP88.2371206D21016547-701-7-2-6-8-1-26-49-43
6/15/11 15:01
6/14/11
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADP163.57052257D-223-90-12-4-6-3-1-15-6-87
12/3/08 17:32
12/1/08
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADP73.5002450D29-25-33-28-40101-7-14-12123
12/2/08 19:51
12/1/08
DEPODepomed IncCAHealthDrugPharmaceutical PreparationsDawes Karen ACADP71.4405New5D-59-50-60-66-34-20410-1591774131
9/5/06 13:46
9/1/06
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagDawes Karen AMADP73.3302New2D108-15-212382-224-1-1-11-241

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact